Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cathie Wood, founder and chief executive officer of ARK Investment Management, joined Bloomberg on June 9 and defended her ARK Innovation ETF, which has been notably battered from its peak in the COVID...
The Business Research Company’s Specialty Enzymes Global Market Report 2022: Market Size, Trends, And Forecast To 2026
Codexis (NASDAQ:CDXS – Get Rating) and Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares Codexis and Cyclo Therapeutics’ net margins, […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) has earned an average rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average […]
[296 Pages Report] The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the global market. Due to increasing demand for novel drugs option, there has been rising applications of drug intermedi...